Wells Fargo analyst Finian O’Shea maintained a Buy rating on Bain Capital Specialty Finance (BCSF – Research Report) today and set a price ...

Analyst Whit Mayo of Leerink Partners reiterated a Buy rating on Surgery Partners (SGRY – Research Report), with a price target of ...

Bain Capital Specialty Finance has shown strong performance with impressive earnings and solid portfolio quality. Read why I ...

Frontline will continue to be led by CEO Mitch Williams, and the current management team, who will remain significant investors in the company.

In a notable performance, Bain Capital Specialty Finance (NYSE:BCSF) stock has reached a 52-week high, trading at $17.97. According to InvestingPro data, the company boasts an attractive 9.44% ...

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities, foreign equities and ...

Financial indicators such as revenue growth, profit margins and return on invested capital (ROIC) were paired with assessments of market positioning, competitive dynamics and regulatory environments.

Lisanti Capital Growth has some investor-friendly attributes, but other attributes warrant caution, leading to an Average Parent Pillar rating. An area of strength for the firm is its relatively ...